Toronto, Ontario–(Newsfile Corp. – November 3, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to announce that it has entered into a share exchange agreement (the "Agreement") with McEwen…

Toronto, Ontario–(Newsfile Corp. – September 19, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") announced today that the closing of its previously announced non-brokered private placement offering of unsecured debentures (the…

Toronto, Ontario–(Newsfile Corp. – July 28, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to announce the launch of a non-brokered private placement offering of unsecured debentures (the "Debentures")…

$5mm treasury investment in asset backed loansLooking to leverage royalty and private debt opportunitiesParagon Advanced Labs progresses towards listingToronto, Ontario–(Newsfile Corp. – July 8, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the…

Toronto, Ontario–(Newsfile Corp. – January 28, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to provide the following corporate update to its shareholders:Sale of UK Operating SubsidiaryAs announced recently,…